Key result
Venous porcine smooth muscle cells demonstrate ~15% greater proliferation and migration versus arterial cells.
Why the study?
The reasons for the prevalence of stenosis in the venous segment compared to the arterial segment in arteriovenous fistulae remain unknown, motivating investigation of protein expression and signaling differences in vascular smooth muscle cells.
Absolute Event Rate: 1.8% vs 1.56%
p-value: p=<0.001
Venous porcine smooth muscle cells exhibit more aggressive proliferation, migration, and signaling pathway activation than arterial cells, providing a potential mechanistic explanation for the high rate of venous stenosis in arteriovenous fistulae.
Arteriovenous fistulae (AVF) are the preferred mode of dialysis vascular access but have a maturation failure rate of over 50%. Venous segment stenosis is one of the main reasons. However, the reasons for the prevalence of stenosis in the venous segment, as opposed to the arterial segment, remain unknown. We hypothesize that differences in the protein expression profiles and in the activation of key signaling pathways of the vascular smooth muscle cells (VSMCs) in these two segments may contribute to this difference. In this study, arterial porcine VSMCs (ApSMCs) and venous porcine VSMCs (VpSMCs) were isolated to examine relevant protein expression and cell signaling pathway activation via Western blots and immunofluorescent staining. Our results revealed that growth-medium-stimulated cell proliferation was significantly higher in VpSMCs compared to ApSMCs, but no difference was detected in PDGF-BB-stimulated proliferation. VpSMCs migration was significantly greater than ApSMCs under both the serum-free condition and in the growth medium condition. In addition, VpSMCs appeared more susceptible to PDGF-BB-stimulated cell dedifferentiation. Furthermore, P53, vitronectin, collagen 1A1 and integrin β3 had lower expression in VpSMCs, whereas fibronectin, FAK, VCAM-1, MMP-9, TIMP-2 and TIMP-3 had higher expression as compared to ApSMCs. Meanwhile, PDGF-BB stimulated P38, JNKs and AKT activation, which were more potent in VpSMCs. Our results identify significant differences between VpSMCs and ApSMCs in the expression of functional proteins and the activation of signaling pathways, which may be responsible for more aggressive venous-as compared to arterial-stenosis in the clinical setting of arteriovenous access or other similar procedures.
No takes yet. Share an insight, caveat, or question.
Arteaga et al. (2025) studied Arteriovenous fistulae (AVF) stenosis. Venous origin (VpSMCs) vs. Arterial origin (ApSMCs) was evaluated on Cell proliferation at 48 hours (fold increase) (p=<0.001). Venous porcine smooth muscle cells demonstrated significantly higher proliferation (1.80-fold vs 1.56-fold increase, p<0.001) and migration compared to arterial cells.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: